Create Medic (5187) Q1 2025 earnings summary

Executive summary

• Net sales for Q1 2025 rose 8.2% year-over-year to ¥3,220 million, with operating profit up 125% to ¥221 million and ordinary profit up 102.2% to ¥215 million.

• Profit attributable to owners of parent increased 254% year-over-year to ¥209 million, while comprehensive income turned negative at ¥(193) million compared to ¥452 million last year.

Financial highlights

• Basic earnings per share for Q1 2025 was ¥24.38, up from ¥6.51 in Q1 2024.

• Total assets as of March 31, 2025 were ¥19,101 million, with net assets at ¥15,350 million.

• Capital adequacy ratio improved to 80.4% from 78.6% at the previous year-end.

Outlook and guidance

• Full-year 2025 net sales forecast at ¥13,583 million, up 4.2% year-over-year.

• Operating profit projected to rise 44.7% to ¥1,002 million, with ordinary profit up 39.0% to ¥1,043 million.

• Profit attributable to owners of parent expected to decrease 5.3% to ¥796 million, with full-year EPS forecast at ¥92.67.